Correction. Ketamine vs Electroconvulsive Therapy in the Management of Treatment-Resistant Depression: Do We Need More Data?

The Journal of Clinical Psychiatry February 11, 2025 correction DOI: 10.4088/JCP.25lcx15827 (opens in new tab) via PubMed

Read Full Text

Relevant Not relevant

Summary

AI-generated from the abstract

This is a correction notice for a previously published article. It identifies the original article by its DOI but provides no new findings, arguments, or data.

Study at a glance

Topics	Depression
Keywords	Depression treatment Ketamine therapy Electroconvulsive therapy Psychiatric interventions

Abstract

This corrects the article DOI: 10.4088/JCP.24br15655.

Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine? JAMA Psychiatry December 1, 2023 8 citations
Review on the Comparative Effectiveness of Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression Pakistan Journal of Medicine and Dentistry September 29, 2025
KET or ECT for treatment-resistant depression? International journal of psychiatry in clinical practice January 1, 2024 via PubMed
Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians. Focus (American Psychiatric Publishing) April 1, 2025 2 citations via PubMed
Corrigendum to "Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study". Ther Adv Psychopharmacol May 19, 2026 via PubMed Central

Explore topics

Depression

Comments

No comments yet.